One hundred eighty-seven patients with confirmed diffuse non-Hodgkin's lymphoma were selected from a consecutive series of 391 patients who were evaluated and treated a t Stanford University Medical Center. Lymphomas with any degree of nodularity and diffuse lymphomas of "well-differentiated" and "p
Clinical significance of morphologic subdivision in diffuse large cell lymphoma
β Scribed by Larry W. Kwak; Morgan Wilson; Lawrence M. Weiss; Sandra J. Horning; Roger A. Warnke; Ronald F. Dorfman
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 525 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Recent studies have suggested that chromosomal aberrations of the MYC gene locus indicate an unfavorable prognosis in diffuse large Bβcell lymphoma (DLBCL). However, there have been few reports on MYC translocation in Chinese patients. One hundred and six cases of DLBCLs were analyzed u
## Abstract Diffuse large Bβcell lymphoma (DLBCL) is a biologically heterogeneous disease for which the current approach to treatment is only successful for 50% of patients. The prognostic value of various clinical and biological factors in predicting treatment outcome is discussed in this paper. A
## Abstract The Fβbox protein Skp2 positively regulates the G1βS transition by promoting degradation of the cyclinβdependent kinase inhibitor p27^kip1^ (p27). Recent evidence has suggested an oncogenic role of Skp2 in not only carcinogenesis but also lymphomagenesis. In this study, we performed imm